Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Hamilton Robotics Launches Microlab® Immunostain NIMBUS® Workstation
Tuesday, January 28, 2014
The Immunostain NIMBUS provides hands-free fluorescent staining at an affordable price.

Aptamer Kits for Cell Isolation & Flow Cytometry
Monday, January 27, 2014
Deliver unmatched convenience, increased consistency and reliability.

PerkinElmer Introduces Novel Research Tools at SLAS 2014
Monday, January 27, 2014
PerkinElmer Inc. introduced several novel products at SLAS2014, including the Opera® Phenix™ high content screening system, JANUS® chemagic nucleic acid workstation.

Techne’s New Range of Dri-block® Heaters Given a New Look and Increased Functionality
Thursday, January 16, 2014
Enhanced levels of choice, flexibility and specification are offered.

Compugen to Significantly Expand Immuno-Oncology Activities During 2014
Wednesday, January 08, 2014
R&D expenditures for 2014 anticipated to increase by more than 60%.

New Anti-GABAB1 Receptor Antibody from AbboMax
Thursday, December 19, 2013
Recent progress in neuroscience research from the Company.

TELOS MicroPlate™ from Kinesis – a versatile 96-well SPE format for small volume biological fluid samples
Monday, December 16, 2013
The TELOS MicroPlate™ is a versatile 96-well plate for the extraction of drug molecules from small volume biological fluid samples.

Tecan’s Cavro® Air Displacement Pipettor
Wednesday, December 11, 2013
Proves ideal for new microbiology application.

York's Biology Department Buys their EM Supplies from Agar
Wednesday, December 11, 2013
Company provides microscopy services to researchers of all levels of expertise.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 362
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv